Epstein Secrets

CTORIA R KAUFMANN,MAXIMILLIAN LAVAN,SPENCER WOOLEMS,HEATHER ZEITZ,GLENN

HENKIN,EDWARD R POKLEPOVIC,DR JERRY MARINO,VERA GRETCHYN PALM BEACH ORTHODOX SYNAGOGU

by other forms of muscular dystrophy. "Muscle studies have been underfunded forever and certainly a rare disease like 2a especially underfunded," Spencer says. In 2010, Wrubel formed the nonprofit Coalition to Cure Calpain 3. In the quest for a cure, she says, "It's a matter of patients taking charg

ve each of the family member's genomes sequenced. The genome tests gave Ivana and Antonia the bad news about calpainopathy. Their younger brother, Mario, is free of the disease. Scientists classify calpainopathy, or "calpain," as a limb-girdle muscular dystrophy Type 2a, caused by a mutation in the

have each of the family member’s genomes sequenced. The genome tests gave Ivana and Antonia the bad news about calpainopathy. Their younger brother, Mario, is free of the disease. Scientists classify calpainopathy, or “calpain,” as a limb-girdle muscular dystrophy Type 2a, caused by a mutation in the g

t from orphan drugs because, compared to drugs for common afflictions, they often have shorter and less expensive clinical trials, with more success. Spencer says a drug for calpamnopathy, for instance, would also be useful for patients with Lou Gehrig’s Disease and bed rest patients, as it would help arre

wed by other forms of muscular dystrophy. “Muscle studies have been underfunded forever and certainly a rare disease like 2a especially underfunded,” Spencer says. In 2010, Wrubel formed the nonprofit Coalition to Cure Calpain 3. In the quest for a cure, she says, “It’s a matter of patients taking charge